US Federal 2025-2026 Regular Session

US Federal House Bill HB1396

Introduced

2/14/25

Refer

2/14/25

Caption

PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of medicine Act

Latest US HB1396 Activity

View All Events: US 2025-2026 Regular Session HB1396

Companion Bills

US SB1891

Same As PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of medicine Act

Previously Filed As

US SB1891

PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of medicine Act

US SB4189

INSULIN Act of 2026 Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026

US SB1553

Authorizes incentives for producing certain critical materials and pharmaceuticals

US HB8143

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

US SB4323

Ensuring Access to Lower-Cost Medicines for Seniors Act

US HB1725

Increasing access to biosimilar medicines.

US SB140

To Mandate The Use Of Biosimilar Medicines Under Health Benefit Plans; To Require A Healthcare Provider To Prescribe Biosimilar Medicines; And To Improve Access To Biosimilar Medicines.

US HB2391

Strengthening Supply Chains Through Truck Driver Incentives Act of 2025

US SB34

Prescription drugs; creating the Access to Lifesaving Medicines Act; prohibiting certain costs and requiring rebates under certain plans. Effective date.

US SB34

Prescription drugs; creating the Access to Lifesaving Medicines Act; prohibiting certain costs and requiring rebates under certain plans. Effective date.

Similar Bills

No similar bills found.